REC is a state-owned financial institution that provides long-term loans and credit solutions to power utilities and infrastructure projects across India, earning income from interest spreads on its lending portfolio.
The company possesses a wide moat derived from its 'Maharatna' status and sovereign backing, which allows it to borrow at rates significantly lower than private competitors. This cost advantage is corroborated by a durable net interest margin of 3.6-3.7% despite high leverage and competition from commercial banks.
Management has consistently prioritized high-yielding power projects while expanding into infrastructure and logistics to diversify risk. They maintain a disciplined dividend policy, returning roughly 30% of profits to shareholders while keeping capital adequacy well above regulatory requirements.
The collapse was driven by a systemic insolvency crisis among state distribution companies, turning the concentrated Stage-2 assets into massive write-offs that the thin 1.57x interest coverage could not absorb. As foreign currency hedging failed during a global liquidity crunch, mark-to-market losses compounded with the negative cash conversion cycle to trigger a liquidity trap. The sovereign backing proved to be a ceiling rather than a floor, as the government prioritized consumer subsidies over the lender's balance sheet, leading to a permanent impairment of equity value.
RichFakir rates REC Ltd's business quality as wonderful — 75/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as wide.
On our model, REC Ltd is trading about 11% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on REC Ltd is: Buy candidate. A wonderful business trading below what we think it is worth — so it makes our buy list.
RichFakir's educational estimate of REC Ltd's fair value is about ₹321 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →